Premium
Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular performance in dogs with chronic heart failure
Author(s) -
Stanley W.C.,
Mishima T.,
Biesiadeck B.J.,
Suzuki G.,
Chaudhry P.,
Nass O.,
Sabbah H.N.
Publication year - 2000
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1016/s1388-9842(00)80346-3
Subject(s) - heart failure , medicine , ranolazine